Accessibility Menu
Amesite logo

Amesite(NASDAQ) AMST

Current Price$0.99
Market Cap$6.23MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)-98%
5 Year-96%
1 Year-70%
1 Month-16%
Amesite last closing stock price
MetricPriceDate
Last closeUSD 0.952026-07-23
Amesite stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-9.34%USD 1.052026-07-16
1 month-15.76%USD 1.132026-06-23
3 month-39.75%USD 1.582026-04-24
Year to date-49.63%USD 1.892025-12-31
1 year-70.35%USD 3.212025-07-23
3 year-74.27%USD 3.702023-07-24
5 year-96.09%USD 24.362021-07-23
Since inception-98.36%USD 62.642020-09-25

Amesite Financials at a Glance

Market Cap

$6.23MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$341.44K

Net Income (TTM)

-$2.98M

EPS (TTM)

-$0.65

P/E Ratio

-1.47

Dividend

$0.00

Beta (Volatility)

0.89 (Low)

Price

$0.99

Volume

1,802

Open

$0.98

Previous Close

$0.99

Daily Range

$0.97 - $0.99

52-Week Range

$0.77 - $4.78

Estimated Earnings Date

Jun 3, 2026

AMST News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Amesite

Amesite builds online learning platforms and healthcare apps using artificial intelligence. Its tools help businesses, schools, and nurses work more efficiently. The company’s products aim to simplify training and daily tasks for professionals and students.

What’s in the Amesite Toolbox?

  • AI Learning Platforms: Custom online training for businesses, schools, and universities (74% of Q1 2026 revenue).
  • NurseMagic App: Mobile tool for nurses to manage documentation and patient care (launched 2025; part of healthcare focus).
  • Professional Development: Courses for individuals and organizations to upskill (26% of Q1 2026 revenue).
  • Content Design Services: Builds tailored courses for clients in education and business.
  • Healthcare AI Solutions: New focus on tools for healthcare operations and staff support.

Growth Moves: Amesite’s Expansion Playbook

  • Launched NurseMagic app in 2025, shifting focus to healthcare technology.
  • Expanded from academic clients to business and healthcare sectors since 2024.
  • Increased investment in proprietary software, capitalizing $87,600 in Q1 2026.
  • Raised $3.08 million in a public offering in January 2025.
  • Broadened revenue base, with B2C (individual) sales rising to 26% in Q1 2026.

Why Amesite Gets Noticed

Amesite’s main strength is its use of artificial intelligence to personalize learning and healthcare tools. The company adapts its technology for both organizations and individuals, offering flexibility across markets. Its recent pivot to healthcare aims to address urgent needs in nursing and patient care.

Five Things You Need to Know

  • Revenue was $94,296 in Q1 2026, up 738.2% from Q1 2025.
  • B2B customers made up 74% of Q1 2026 revenue; B2C was 26%.
  • Net loss was $642,266 in Q1 2026, improving 29.3% year-over-year.
  • Cash and equivalents totaled $1.93 million as of September 30, 2025.
  • Management sees substantial doubt about continuing operations without new funding.

Bottom Line

Amesite has shifted from education to healthcare, using AI to serve new markets. The company remains early-stage, with ongoing losses and a need for more capital.

AI Generated • Apr 16, 2026

Industry

Diversified Consumer Services

Sector

Consumer Discretionary

Employees

8

CEO

Ann Marie Sastry, PhD

Website

www.amesite.com

Headquarters

Detroit, MI 48226, US

AMST Financials

Key Financial Metrics (TTM)

Gross Margin

59.26%

Operating Margin

-863.74%

Net Income Margin

-871.86%

Return on Equity

-154.29%

Return on Capital

-131.59%

Return on Assets

-199.47%

Earnings Yield

-68.03%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.23MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

6.55M

Volume

1.80K

Avg. Volume

3.19M

Financials (TTM)

Gross Profit

$202.32K

Operating Income

-$2.95M

EBITDA

-$2.68M

Operating Cash Flow

-$1.93M

Capital Expenditure

-$161.60K

Free Cash Flow

-$2.09M

Cash & ST Invst.

$640.71K

Total Debt

$0.00

Amesite Performance Analysis

Amesite annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30USD 697,001N/A
20232023-06-30USD 845,00921.2%
20242024-06-30USD 166,881-80.3%
20252025-06-30USD 110,459-33.8%
Amesite sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-06-3081.7%
Q12025-09-3069.1%
Q22025-12-3114.6%
Q32026-03-31-22.9%
Amesite annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30USD -4.67N/A
20232023-06-30USD -1.68-64.0%
20242024-06-30USD -1.733.0%
20252025-06-30USD -1.03-40.8%
Amesite sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-06-3016.7%
Q12025-09-3030.0%
Q22025-12-31-14.3%
Q32026-03-316.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$83.33K

+171.5%

Gross Profit

$11.96K

-61.0%

Gross Margin

14.35%

N/A

Market Cap

$6.23MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$779.35K

N/A

Employees

8

N/A

Net Income

-$678.06K

-2.2%

EBITDA

-$606.69K

-7.8%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

$640.71K

-77.6%

Total Debt

$0.00

N/A

Accounts Receivable

$18.98K

+327.4%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-1.99%

N/A

Return on Invested Capital

-2.26%

N/A

Free Cash Flow

-$524.66K

+22.5%

Operating Cash Flow

-$449.16K

+33.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DTSSDatasea Intelligent Technology Ltd.
$0.84+6.40%
AMODAlpha Modus Holdings, Inc.
$3.70-3.39%
CXAICXApp Inc.
$0.12-4.08%
WCTWellchange Holdings Company Limited
$0.82-6.35%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.76-0.29%
NOKNokia
$9.73-0.05%
INTCIntel
$100.23-0.02%
AALAmerican Airlines Group
$13.56-0.08%

Questions About AMST

What is the current price of Amesite?

Amesite is trading at $0.99 per share.

What is the 52-week range for Amesite?

Over the past 52 weeks, Amesite has traded between $0.77 and $4.78.

How much debt does Amesite have?

As of the most recent reporting period, Amesite reported total debt of $0.00.

How much cash does Amesite have on hand?

Amesite reported $640.71K in cash and cash equivalents in its most recent financial results.

What is Amesite’s dividend yield?

Amesite does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services